In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
October 7th, 2004 | 19 | No |
Popular Name: LS-28000 LS-28000
Find On: PubMed — Wikipedia — Google
CAS Numbers: 62717-42-4 , 81633-77-4
(+/-)-1-Phenyl-2,3,4,5-tetrahydro-(1h)-3-benzazepine-7,8-diol hydrochloride
1-phenyl-2,3,4,5-tetrahydro-(1h)-3-benzazepine-7,8-diolhydrobromide
1-Phenyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine-7,8-diol hydrochloride
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 1.94 | 3.4 | -51.54 | 4 | 3 | 1 | 57 | 256.325 | 1 | ↓ |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
ADCY2-2-E | Adenylate Cyclase Type II (cluster #2 Of 2), Eukaryotic | Eukaryotes | 71 | 0.53 | Binding ≤ 10μM |
ADCY3-2-E | Adenylate Cyclase Type III (cluster #2 Of 2), Eukaryotic | Eukaryotes | 71 | 0.53 | Binding ≤ 10μM |
ADCY4-2-E | Adenylate Cyclase Type IV (cluster #2 Of 2), Eukaryotic | Eukaryotes | 71 | 0.53 | Binding ≤ 10μM |
ADCY5-2-E | Adenylate Cyclase Type V (cluster #2 Of 2), Eukaryotic | Eukaryotes | 71 | 0.53 | Binding ≤ 10μM |
ADCY6-2-E | Adenylate Cyclase Type VI (cluster #2 Of 2), Eukaryotic | Eukaryotes | 71 | 0.53 | Binding ≤ 10μM |
ADCY8-1-E | Adenylate Cyclase Type VIII (cluster #1 Of 2), Eukaryotic | Eukaryotes | 71 | 0.53 | Binding ≤ 10μM |
D4A3N4-1-E | Brain Adenylate Cyclase 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 71 | 0.53 | Binding ≤ 10μM |
DRD1-1-E | Dopamine D1 Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 25 | 0.56 | Binding ≤ 10μM |
DRD1-1-E | Dopamine D1 Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 26 | 0.56 | Binding ≤ 10μM |
Q8CFM9-1-E | Adenylate Cyclase Type VII (cluster #1 Of 1), Eukaryotic | Eukaryotes | 71 | 0.53 | Binding ≤ 10μM |
DRD2-2-E | Dopamine D2 Receptor (cluster #2 Of 24), Eukaryotic | Eukaryotes | 8800 | 0.37 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
ADCY2_RAT | P26769 | Adenylate Cyclase Type II, Rat | 32 | 0.55 | Binding ≤ 1μM |
ADCY3_RAT | P21932 | Adenylate Cyclase Type III, Rat | 32 | 0.55 | Binding ≤ 1μM |
ADCY4_RAT | P26770 | Adenylate Cyclase Type IV, Rat | 32 | 0.55 | Binding ≤ 1μM |
ADCY5_RAT | Q04400 | Adenylate Cyclase Type V, Rat | 32 | 0.55 | Binding ≤ 1μM |
ADCY6_RAT | Q03343 | Adenylate Cyclase Type VI, Rat | 32 | 0.55 | Binding ≤ 1μM |
Q8CFM9_RAT | Q8CFM9 | Adenylate Cyclase Type VII, Rat | 32 | 0.55 | Binding ≤ 1μM |
ADCY8_RAT | P40146 | Adenylate Cyclase Type VIII, Rat | 32 | 0.55 | Binding ≤ 1μM |
D4A3N4_RAT | D4A3N4 | Brain Adenylate Cyclase 1, Rat | 32 | 0.55 | Binding ≤ 1μM |
DRD1_HUMAN | P21728 | Dopamine D1 Receptor, Human | 26 | 0.56 | Binding ≤ 1μM |
DRD2_HUMAN | P14416 | Dopamine D2 Receptor, Human | 160 | 0.50 | Binding ≤ 1μM |
ADCY2_RAT | P26769 | Adenylate Cyclase Type II, Rat | 32 | 0.55 | Binding ≤ 10μM |
ADCY3_RAT | P21932 | Adenylate Cyclase Type III, Rat | 32 | 0.55 | Binding ≤ 10μM |
ADCY4_RAT | P26770 | Adenylate Cyclase Type IV, Rat | 32 | 0.55 | Binding ≤ 10μM |
ADCY5_RAT | Q04400 | Adenylate Cyclase Type V, Rat | 32 | 0.55 | Binding ≤ 10μM |
ADCY6_RAT | Q03343 | Adenylate Cyclase Type VI, Rat | 32 | 0.55 | Binding ≤ 10μM |
Q8CFM9_RAT | Q8CFM9 | Adenylate Cyclase Type VII, Rat | 32 | 0.55 | Binding ≤ 10μM |
ADCY8_RAT | P40146 | Adenylate Cyclase Type VIII, Rat | 32 | 0.55 | Binding ≤ 10μM |
D4A3N4_RAT | D4A3N4 | Brain Adenylate Cyclase 1, Rat | 32 | 0.55 | Binding ≤ 10μM |
DRD1_HUMAN | P21728 | Dopamine D1 Receptor, Human | 26 | 0.56 | Binding ≤ 10μM |
DRD2_HUMAN | P14416 | Dopamine D2 Receptor, Human | 160 | 0.50 | Binding ≤ 10μM |
Description | Species |
---|---|
Adenylate cyclase activating pathway | |
Adenylate cyclase inhibitory pathway | |
CREB phosphorylation through the activation of Adenylate Cyclase | |
Dopamine receptors | |
G alpha (i) signalling events | |
G alpha (s) signalling events | |
G alpha (z) signalling events | |
Glucagon signaling in metabolic regulation | |
PKA activation | |
PKA activation in glucagon signalling | |
Vasopressin regulates renal water homeostasis via Aquaporins |